These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 324057)

  • 1. [Clinical--pharmacological aspects of treatment with sodium di-n-propylacetate].
    Wulff K; Flachs H; Würtz-Jørgensen A; Gram L
    Ugeskr Laeger; 1977 May; 139(18):1059-64. PubMed ID: 324057
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sodium di-n-propylacetate, effect in the treatment of resistant epilepsy. A controlled study].
    Gram L; Wulff K; Rasmussen KE; Flachs H; Würtz-Jørgensen A; Sommerbeck KW; Løhren V
    Ugeskr Laeger; 1977 May; 139(18):1064-9. PubMed ID: 324058
    [No Abstract]   [Full Text] [Related]  

  • 3. [Sodium di-n-propylacetate: evaluation of its so-called psychotropic effect. A controlled study].
    Sommerbeck KW; Theilgaard A; Rasmussen KE; Løhren V; Gram L; Wulff K
    Ugeskr Laeger; 1977 May; 139(18):1069-73. PubMed ID: 324059
    [No Abstract]   [Full Text] [Related]  

  • 4. Progressive myoclonic epilepsy. The response to sodium di -- n -- propylacetate.
    Tomlinson EB
    Proc Aust Assoc Neurol; 1974; 11():203-8. PubMed ID: 4620029
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings: A controlled trial of sodium valproate in severe epilepsy.
    Richens A
    Electroencephalogr Clin Neurophysiol; 1975 Oct; 39(4):428. PubMed ID: 51730
    [No Abstract]   [Full Text] [Related]  

  • 6. [Valproic acid in the treatment of epilepsy with special emphasis on serum level determination (author's transl)].
    Fröscher W; Schulz HU; Gugler R
    Fortschr Neurol Psychiatr Grenzgeb; 1978 Jun; 46(6):327-41. PubMed ID: 352872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Trial of a new antiepileptic drug, magnesium dipropyl acetate].
    de Pasquet EG; Gomensoro JB; de Bustos LF; Tenzer SM
    Acta Neurol Latinoam; 1973; 19(1-4):119-28. PubMed ID: 4619958
    [No Abstract]   [Full Text] [Related]  

  • 8. Valproic acid in epilepsy: clinical and pharmacological effects.
    Mattson RH; Cramer JA; Williamson PD; Novelly RA
    Ann Neurol; 1978 Jan; 3(1):20-5. PubMed ID: 350128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of pyknoleptic petit mal epilepsy and juvenile myoclonic epilepsy with dipropyl acetate (Deprakine). A pilot study of therapy-resistant patients during control of plasma concentration].
    Schroll M; Naestoft J; Lund M
    Ugeskr Laeger; 1977 May; 139(18):1073-7. PubMed ID: 404744
    [No Abstract]   [Full Text] [Related]  

  • 10. [Modification of personality changes in epileptics using dipropylacetate (Convulex). Preliminary communication].
    Deisenhammer E
    Wien Med Wochenschr; 1977 Jun; 127(12):370-3. PubMed ID: 333779
    [No Abstract]   [Full Text] [Related]  

  • 11. The anticonvulsant effect of sodium valproate and clonazepam in the management of intractable epilepsy.
    Lance JW; Anthony M
    Trans Am Neurol Assoc; 1976; 101():200-4. PubMed ID: 800689
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experiences with sodium 2-propyl valerate (Depakine) in the treatment of epilepsy].
    Trompetter-van Woerden ML; van der Zwan A
    Ned Tijdschr Geneeskd; 1977 Apr; 121(14):578-90. PubMed ID: 323732
    [No Abstract]   [Full Text] [Related]  

  • 13. Sodium valproate in epilepsy.
    Lancet; 1977 Oct; 2(8043):860. PubMed ID: 72202
    [No Abstract]   [Full Text] [Related]  

  • 14. Valproate sodium: a controlled clinical trial including monitoring of drug levels.
    Gram L; Wulff K; Rasmussen KE; Flachs H; Würtz-Jorgensen A; Sommerbeck KW; Lohren V
    Epilepsia; 1977 Jun; 18(2):141-8. PubMed ID: 326542
    [No Abstract]   [Full Text] [Related]  

  • 15. [Problems in serum-level determination during valproic acid therapy].
    Schäfer H; Reith H; Jacobs R; Gabriel KH
    Arzneimittelforschung; 1977; 27(6):1215-21. PubMed ID: 332187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproic acid and sodium valproate approved for use in epilepsy.
    FDA Drug Bull; 1978; 8(2):14-5. PubMed ID: 344120
    [No Abstract]   [Full Text] [Related]  

  • 17. Controlled trial of sodium valproate in severe epilepsy.
    Richens A; Ahmad S
    Br Med J; 1975 Nov; 4(5991):255-6. PubMed ID: 1104059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proceedings: Sodium valproate (Epilim) in the treatment of intractable epilepsy, including some observations on blood levels.
    Scott DF; Lloyd MH; France M; Hamilton C; Cohne RD
    Electroencephalogr Clin Neurophysiol; 1975 Oct; 39(4):429. PubMed ID: 51736
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prophylactic and anticonvulsive effects of di--N--propylacetate examined in kindling cat preparations (author's transl)].
    Sato M; Nakashima T; Nagao T; Ohshimo T; Wake A; Tomoda T; Otsuki S
    No To Shinkei; 1977 Dec; 29(12):1267-75. PubMed ID: 339931
    [No Abstract]   [Full Text] [Related]  

  • 20. [Sodium dipropyl acetate in the prevention of febrile convulsions in children].
    Galli V; Gatti G; Massolo F; Nalin A; Rozzi N; Tamborino G
    Acta Neurol (Napoli); 1977; 32(6):884-91. PubMed ID: 343515
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.